UroGen Pharma Ltd.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC URGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

90,989

Value ($000)

2,131

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,131	0.0%	90,989	12/31/2025
2025 Q3	11/10/2025	1,817	0.0%	91,059	9/30/2025
2025 Q2	8/12/2025	1,273	0.0%	92,898	6/30/2025
2025 Q1	9/15/2025	1,035	0.0%	93,547	3/31/2025
2024 Q4	2/6/2025	996	0.0%	93,517	12/31/2024
2024 Q3	11/12/2024	1,149	0.0%	90,493	9/30/2024
2024 Q2	8/12/2024	1,391	0.0%	82,917	6/30/2024
2024 Q1	5/9/2024	943	0.0%	62,880	3/31/2024
2023 Q4	2/6/2024	943	0.0%	62,880	12/31/2023
2023 Q3	11/8/2023	650	0.0%	46,394	9/30/2023
2023 Q2	8/10/2023	463	0.0%	44,724	6/30/2023
2022 Q1	5/13/2022	372	0.0%	42,689	3/31/2022
2021 Q4	2/11/2022	406	0.0%	42,689	12/31/2021
2021 Q3	11/16/2021	719	0.0%	42,689	9/30/2021
2021 Q2	8/16/2021	619	0.0%	40,515	6/30/2021
2021 Q1	5/17/2021	796	0.0%	40,853	3/31/2021
2020 Q4	2/16/2021	740	0.0%	41,036	12/31/2020
2020 Q3	11/13/2020	772	0.0%	39,970	9/30/2020
2020 Q2	8/20/2020	1,092	0.0%	41,796	6/30/2020
2020 Q1	5/15/2020	724	0.0%	40,564	3/31/2020
2019 Q4	2/7/2020	1,347	0.0%	40,354	12/31/2019